Takeda Pharmaceutical Company Limited, a research-based global company, announced its participation in WIPO Re:Search, a consortium to accelerate research and ...
Read More
- GBR 1302, a HER2xCD3 bi-specific antibody has successfully completed the preclinical evaluation phase
- Preclinically, GBR 1302 has demonstrated superiority ...
Read More